SRC
BMY icon

Sage Rhino Capital’s Bristol-Myers Squibb BMY Stock Holding History

Sage Rhino Capital’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,375
Closed -$203K – 306
2025
Q2 		$203K Sell
4,375
-149
-3% -$7.31K 0.04% 244
2025
Q1 		$276K Buy
4,524
+246
+6% +$14.3K 0.06% 177
2024
Q4 		$242K Buy
4,278
+56
+1% +$3.13K 0.05% 198
2024
Q3 		$218K Buy
+4,222
New +$198K 0.05% 230
2024
Q2 		– Sell
-3,884
Closed -$211K – 253
2024
Q1 		$211K Sell
3,884
-86
-2% -$4.38K 0.05% 204
2023
Q4 		$204K Sell
3,970
-187
-4% -$9.82K 0.05% 202
2023
Q3 		$241K Sell
4,157
-103
-2% -$6.31K 0.07% 176
2023
Q2 		$272K Sell
4,260
-292
-6% -$19.6K 0.08% 171
2023
Q1 		$315K Buy
4,552
+239
+6% +$16.9K 0.09% 154
2022
Q4 		$310K Buy
4,313
+74
+2% +$5.58K 0.1% 154
2022
Q3 		$301K Sell
4,239
-86
-2% -$6.24K 0.12% 128
2022
Q2 		$333K Buy
4,325
+72
+2% +$5.48K 0.13% 134
2022
Q1 		$311K Sell
4,253
-11
-0.3% -$739 0.09% 160
2021
Q4 		$266K Sell
4,264
-3,682
-46% -$216K 0.07% 178
2021
Q3 		$470K Buy
7,946
+10
+0.1% +$659 0.14% 112
2021
Q2 		$530K Sell
7,936
-2,238
-22% -$146K 0.16% 104
2021
Q1 		$642K Buy
10,174
+25
+0.2% +$1.55K 0.21% 85
2020
Q4 		$630K Sell
10,149
-89
-0.9% -$5.47K 0.25% 75
2020
Q3 		$617K Sell
10,238
-290
-3% -$17.5K 0.3% 66
2020
Q2 		$619K Buy
10,528
+209
+2% +$12.5K 0.33% 64
2020
Q1 		$575K Buy
10,319
+303
+3% +$18.5K 0.41% 51
2019
Q4 		$653K Buy
10,016
+4,931
+97% +$282K 0.37% 60
2019
Q3 		$258K Buy
5,085
+324
+7% +$15.2K 0.16% 113
2019
Q2 		$216K Sell
4,761
-66
-1% -$3.07K 0.14% 119
2019
Q1 		$230K Buy
+4,827
New +$240K 0.15% 110

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sage Rhino Capital's BMY Position: Q3 2025 in Review

Sage Rhino Capital sold out of Bristol-Myers Squibb (BMY) in Q3 2025, closing a stake of 4,375 shares — an estimated $203K sold.

Sage Rhino Capital first reported a position in BMY in Q1 2019 and held it in 25 quarters. The position peaked at $653K in Q4 2019. 2,267 funds tracked by Wall St. Rank hold BMY as of Q3 2025.

  • Sage Rhino Capital reported no remaining Bristol-Myers Squibb position as of Q3 2025 after selling out during the quarter.
  • Sage Rhino Capital sold 4,375 Bristol-Myers Squibb shares in Q3 2025, an estimated $203K.
  • Sage Rhino Capital first reported a position in Bristol-Myers Squibb in Q1 2019 and held it in 25 quarters.
  • Sage Rhino Capital's Bristol-Myers Squibb position peaked at $653K in Q4 2019.
  • 2,267 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.

Based on Sage Rhino Capital's 13F filing for Q3 2025, filed 31 Oct 2025.